Skip to main navigation Skip to search Skip to main content

Atypical Pathogens Presenting With Pulmonary Consolidations Detected by Cell-Free DNA Next-Generation Sequencing in Patients With Hematologic Malignancies

  • Mario Caldararo
  • , Jumanah Algazaq
  • , Elizabeth Schmidt
  • , Alexa Joanow
  • , Amanda Mariano
  • , Jacqueline Predmore
  • , Ioannis Politikos
  • , Christina Cho
  • , Eytan M. Stein
  • , Xiaoyun Wen
  • , William D. Travis
  • , Kevin Raible
  • , Melvili Cintron
  • , N. Esther Babady
  • , Genovefa Papanicolaou
  • , Yeon Joo Lee
  • Memorial Sloan-Kettering Cancer Center
  • Cornell University

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Identification of pathogens with pulmonary presentation in patients with hematologic malignancies may be challenging because of diagnostic difficulty related to the underlying malignancy and limitations of conventional microbiologic methods. Herein, we present a case series of 3 patients with pulmonary consolidations due to Legionella bozemanae necrotizing pneumonia, Pneumocystis jirovecii pneumonia, and disseminated Scedosporium infection, who were diagnosed by microbial cell-free DNA next-generation sequencing. We observed that this new sequencing modality was in agreement with criterion standard diagnostics, posing a potential solution to the problem of limited capability in diagnosing infections in hematological malignancy patients.

Original languageEnglish
Article number00015
JournalInfectious Diseases in Clinical Practice
Volume30
Issue number2
DOIs
StatePublished - 1 Mar 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Atypical pathogen
  • Cell-free DNA next-generation sequencing
  • Karius

Fingerprint

Dive into the research topics of 'Atypical Pathogens Presenting With Pulmonary Consolidations Detected by Cell-Free DNA Next-Generation Sequencing in Patients With Hematologic Malignancies'. Together they form a unique fingerprint.

Cite this